AACR Archives

TGen breast cancer study is journal’s most cited


At its Annual Meeting, the American Association for Cancer Research (AACR) announced that a scientific paper describing potential drug targets following the unprecedented genomic sequencing of 14 metastatic triple-negative breast cancer patients was the most cited study in 2013 of any published that year by AACR’s journal Molecular Cancer Therapeutics. In the study, genomic sequencing… Read More →

CTCA hosts its first cancer treatments conference


Cancer Treatment Centers of America® (CTCA) at Western Regional Medical Center (Western) is hosting its first ever Annual New Treatments in Oncology (ANTO) conference, focused on advances in cancer research, new treatments and patient care. The two-day ANTO event will take place on May 1-2 at the W Scottsdale hotel. “We believe we have a… Read More →

TGen’s Barrett awarded $200,000 research grant


The Pancreatic Cancer Action Network and the American Association for Cancer Research (AACR) awarded a $200,000 grant today to Dr. Michael Barrett of the Translational Genomics Research Institute (TGen). Dr. Barrett, an Associate Professor in TGen’s Clinical Translational Research Division, was one of 14 “outstanding scientists” across the nation named to receive a total of… Read More →

TGen-Scottsdale Healthcare battle tumor growth

clinical research advantage - vaccines

The safety and preliminary efficacy of a new class of tumor fighting drugs were reported by Scottsdale Healthcare’s Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen). Early results from the phase I, first in-human study of an RNA interface (RNAi) drug were announced during the American Association for Cancer… Read More →